Lanreotide depot/autogel before, during, and after peptide receptor radionuclide therapy in advanced neuroendocrine tumors: data from the PRELUDE study (*)
Prasad, V Srirajaskanthan, R Toumpanakis, C Grana, C Baldari, S Shah, T Lamarca, Angela Courbon, F Scheidhauer, K Baudin, E
Prasad, V
Srirajaskanthan, R
Toumpanakis, C
Grana, C
Baldari, S
Shah, T
Lamarca, Angela
Courbon, F
Scheidhauer, K
Baudin, E
Citations
Altmetric:
Abstract
Affiliation
Description
Date
2019
Publisher
Collections
Keywords
Type
Meetings and Proceedings
Citation
Prasad V, Srirajaskanthan R, Toumpanakis C, Grana C, Baldari S, Shah T, et al. Lanreotide depot/autogel before, during, and after peptide receptor radionuclide therapy in advanced neuroendocrine tumors: data from the PRELUDE study (*). Pancreas. 2019; 48(3):448-9.